Direct inhibitors for Olfr819 are not well-characterized, leading to the consideration of indirect modulation through chemicals that influence olfactory GPCR signaling pathways. Forskolin, IBMX, and U73122 are examples that modulate second messengers like cAMP and intracellular signaling molecules, which are crucial in GPCR-mediated responses. Pertussis toxin and BAPTA-AM provide insights into the role of G-proteins and calcium in GPCR signaling, which are essential components in the functioning of olfactory receptors.
Furthermore, kinase inhibitors like Genistein, PD98059, LY294002, Wortmannin, SB203580, GF109203X, and Go 6983 target various signaling cascades that can indirectly impact GPCR activity. These inhibitors offer a broader perspective on the signaling networks associated with olfactory receptors, providing an indirect approach to understanding and potentially modulating the activity of receptors like Olfr819. However, the specificity of these chemicals towards Olfr819 is not established, and their effects on this particular receptor require careful experimental validation. This approach allows for exploring the complex signaling mechanisms in olfactory perception and potentially identifying novel modulators of olfactory receptors.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, potentially modulating GPCR signaling including that of Olfr819. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-selective phosphodiesterase inhibitor, affecting cAMP levels and possibly GPCR signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Modifies G-proteins, potentially affecting Olfr819 signaling cascade. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Calcium chelator, can influence signaling pathways of GPCRs. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor, may indirectly affect GPCR signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, potentially affecting MAPK/ERK pathways downstream of GPCR activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, potentially affecting signaling pathways downstream of GPCRs. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, potentially influencing signaling pathways related to GPCR activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, may affect GPCR-related signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Protein kinase C inhibitor, might influence GPCR signaling. | ||||||